Sally Lettis

Once-daily inhaled fluticasone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: two replicate double-blind, parallel-group, randomised controlled trials

Mark T. Dransfield, Jean Bourbeau, Paul Jones et al. · The Lancet Respiratory Medicine · 2013 · 359 citations

Medicine, Internal Medicine, Pharmacotherapy +13

Blood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPD

Ian Pavord, Sally Lettis, Nicholas Locantore et al. · Thorax · 2015 · 326 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease

David A. Lipson, Courtney Crim, Gerard J. Criner et al. · American Journal of Respiratory and Critical Care Medicine · 2020 · 251 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +16

Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial

Steven Pascoe, Neil Barnes, Guy Brusselle et al. · The Lancet Respiratory Medicine · 2019 · 240 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +15

Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients

Sudhesh Kumar, A. J. M. Boulton, Henning Beck‐Nielsen et al. · Diabetologia · 1996 · 239 citations

Medicine, Endocrinology, Pharmacology +16